{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:22:57Z","timestamp":1773422577424,"version":"3.50.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Genitourinary syndrome of menopause (GSM) is a prevalent condition among postmenopausal women, often leading to sexual dysfunction and significantly impacting quality of life. While vaginal estrogen is the standard treatment, alternatives are needed for those who cannot or prefer not to use hormonal therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aims to evaluate the efficacy of radiofrequency (RF) compared with vaginal estrogen in treating sexual dysfunction in postmenopausal women with GSM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search was conducted in PubMed, Embase, and Cochrane Library up to June 2025. Only randomized controlled trials (RCTs) comparing vaginal RF to vaginal estrogen in postmenopausal women with sexual dysfunction were included. Risk of bias was assessed using the Cochrane Risk of Bias 2 tool and certainty of evidence was evaluated using the Grading of Recommendations, Assessment, Development, and Evaluation approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Four RCTs comprising 156 participants were included in the analysis. All trials evaluated sexual function using the Female Sexual Function Index (FSFI), which ranges from 2 to 36, with higher scores indicating better sexual function. The meta-analysis showed that RF improved FSFI total score by 4.85 points compared to vaginal estrogen (95% CI 0.04 to 9.67; P\u2009=\u2009.05). However, no significant differences were observed in the FSFI domains (desire, arousal, lubrication, orgasm, satisfaction, and pain).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>RF appears to be a non-hormonal and potentially promising alternative to vaginal estrogen for managing sexual dysfunction in women with GSM, although its long-term durability requires further investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/sxmrev\/qeag013","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T12:34:54Z","timestamp":1771677294000},"source":"Crossref","is-referenced-by-count":0,"title":["Radiofrequency versus vaginal estrogen for menopausal sexual dysfunction: a systematic review and meta-analysis of randomized clinical trials"],"prefix":"10.1093","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4135-2631","authenticated-orcid":false,"given":"Alice F","family":"Diniz","sequence":"first","affiliation":[{"name":"Department of Medicine, Escola Superior de Ci\u00eancias da Sa\u00fade , Bras\u00edlia, DF , 70710-907,","place":["Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2098-2602","authenticated-orcid":false,"given":"Mariana X","family":"Ciuffatelli","sequence":"additional","affiliation":[{"name":"Department of Medicine, Universidade Santo Amaro , S\u00e3o Paulo, SP , 04629-300,","place":["Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9162-5335","authenticated-orcid":false,"given":"Laura F","family":"Queiroz","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculdade de Ci\u00eancias M\u00e9dicas de Minas Gerais , MG , 30150-221,","place":["Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9778-9624","authenticated-orcid":false,"given":"Maria","family":"Lemos","sequence":"additional","affiliation":[{"name":"Department of Medicine, Centro Universit\u00e1rio Redentor , Itaperuna, RJ , 28300-000,","place":["Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2213-1621","authenticated-orcid":false,"given":"Alessandra","family":"Peloggia","sequence":"additional","affiliation":[{"name":"Department of Medical Education, College of Medicine, University of Central Florida , Orlando, FL, 32827,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"issue":"7","key":"2026031312490194800_ref1","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrendo.2015.82","article-title":"Perimenopause as a neurological transition state","volume":"11","author":"Brinton","year":"2015","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"2026031312490194800_ref2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nrendo.2017.180","article-title":"Symptoms of menopause: global prevalence, physiology and implications","volume":"14","author":"Monteleone","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"2026031312490194800_ref3","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1097\/GME.0000000000000329","article-title":"Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society","volume":"21","author":"Portman","year":"2014","journal-title":"Menopause."},{"key":"2026031312490194800_ref4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.maturitas.2016.09.013","article-title":"Female sexual dysfunction (FSD): prevalence and impact on quality of life (QoL)","volume":"94","author":"Nappi","year":"2016","journal-title":"Maturitas."},{"issue":"1","key":"2026031312490194800_ref5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3109\/13697137.2011.647840","article-title":"Vaginal health: insights, views & attitudes (VIVA)\u2014results from an international survey","volume":"15","author":"Nappi","year":"2012","journal-title":"Climacteric."},{"issue":"7","key":"2026031312490194800_ref6","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1111\/jsm.12190","article-title":"Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of treatment options for menopausal vaginal ChangEs) survey","volume":"10","author":"Kingsberg","year":"2013","journal-title":"J Sex Med"},{"issue":"2","key":"2026031312490194800_ref7","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/gme.0000000000000281","article-title":"Day-to-day impact of Vaginal Aging questionnaire: a multidimensional measure of the impact of vaginal symptoms on functioning and well-being in postmenopausal women","volume":"22","author":"Huang","year":"2014","journal-title":"Menopause."},{"issue":"4","key":"2026031312490194800_ref8","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1097\/gme.0b013e31815a5168","article-title":"Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women","volume":"15","author":"Levine","year":"2008","journal-title":"Menopause."},{"issue":"7","key":"2026031312490194800_ref9","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1097\/GME.0000000000002539","article-title":"Cross-sectional study of the association between regular sexual activity and sexual function and genitourinary syndrome of menopause-related symptoms","volume":"32","author":"Sato","year":"2025","journal-title":"Menopause."},{"key":"2026031312490194800_ref10","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/JU.0000000000004589","article-title":"The AUA\/SUFU\/AUGS guideline on genitourinary syndrome of menopause","volume":"214","author":"Kaufman","year":"2025","journal-title":"J Urol"},{"issue":"5","key":"2026031312490194800_ref11","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1097\/DSS.0000000000001453","article-title":"Histologic and clinical changes in vulvovaginal tissue after treatment with a transcutaneous temperature-controlled radiofrequency device","volume":"44","author":"Vanaman Wilson","year":"2018","journal-title":"Dermatologic Surg"},{"issue":"4","key":"2026031312490194800_ref12","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1590\/S1679-45082017AO4051","article-title":"New therapeutic option in genitourinary syndrome of menopause: pilot study using microablative fractional radiofrequency","volume":"15","author":"Kamilos","year":"2017","journal-title":"Einstein (Sao Paulo)"},{"issue":"9","key":"2026031312490194800_ref13","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1097\/GME.0000000000001609","article-title":"2020 GSM Position Statement Editorial Panel. The 2020 genitourinary syndrome of menopause position statement of the North American Menopause Society","volume":"27","author":"The NAMS","year":"2020","journal-title":"Menopause."},{"key":"2026031312490194800_ref14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.maturitas.2017.06.029","article-title":"Laser therapy for the genitourinary syndrome of menopause: a systematic review and meta-analysis","volume":"103","author":"Pitsouni","year":"2017","journal-title":"Maturitas."},{"key":"2026031312490194800_ref15","doi-asserted-by":"publisher","DOI":"10.1002\/9781119536604","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019","edition":"2nd ed."},{"issue":"7","key":"2026031312490194800_ref16","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"2026031312490194800_ref17","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomized trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ."},{"issue":"7650","key":"2026031312490194800_ref18","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ."},{"issue":"6","key":"2026031312490194800_ref19","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"2026031312490194800_ref20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"2026031312490194800_ref21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/medicina60010080","article-title":"Fractional CO\u2082 laser, radiofrequency and topical estrogen for treating genitourinary syndrome of menopause: a pilot study evaluating the vulvar vestibule","volume":"60","author":"Campos","year":"2023","journal-title":"Medicina (Kaunas)"},{"issue":"6","key":"2026031312490194800_ref22","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1089\/pho.2023.0110","article-title":"Fractional and microablative CO\u2082 LASER and radiofrequency in the treatment of genitourinary syndrome of menopause: a descriptive study","volume":"42","author":"Nogueira","year":"2024","journal-title":"Photobiomodul Photomed Laser Surg"},{"issue":"4","key":"2026031312490194800_ref23","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/GME.0000000000002326","article-title":"Comparison of the effect of noninvasive radiofrequency with vaginal estrogen and vaginal moisturizer in the treatment of vulvovaginal atrophy in postmenopausal women: a randomized clinical trial","volume":"31","author":"Moraes","year":"2024","journal-title":"Menopause."},{"key":"2026031312490194800_ref24","doi-asserted-by":"publisher","first-page":"100293","DOI":"10.1016\/j.clinsp.2023.100293","article-title":"Microablative fractional radiofrequency for sexual dysfunction and vaginal trophism: a randomized clinical trial","volume":"78","author":"Sarmento","year":"2023","journal-title":"Clinics (Sao Paulo)"},{"key":"2026031312490194800_ref25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ejogrb.2025.01.015","article-title":"Sexual function after treatment with non-invasive radiofrequency device for improvement of the genitourinary syndrome of menopause: a multi-arm randomized clinical trial","volume":"306","author":"Moraes","year":"2025","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"12","key":"2026031312490194800_ref26","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1089\/photob.2023.0113","article-title":"Women with genitourinary syndrome of menopause treated with vaginal estriol, microablative fractional CO\u2082 laser and microablative fractional radiofrequency: a randomized pilot study","volume":"41","author":"Oliveira","year":"2023","journal-title":"Photobiomodul Photomed Laser Surg"},{"key":"2026031312490194800_ref27","doi-asserted-by":"publisher","first-page":"108008","DOI":"10.1016\/j.maturitas.2024.108008","article-title":"Comparison of promestriene with vaginal fractional CO\u2082 laser and radiofrequency treatments of genitourinary syndrome of menopause","volume":"186","author":"Seganfredo","year":"2024","journal-title":"Maturitas."},{"issue":"2","key":"2026031312490194800_ref28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/009262300278597","article-title":"The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function","volume":"26","author":"Rosen","year":"2000","journal-title":"J Sex Marital Ther"},{"key":"2026031312490194800_ref29","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s12905-021-01518-8","article-title":"Intravaginal nonablative radiofrequency in the treatment of genitourinary syndrome of menopause symptoms: a single-arm pilot study","volume":"21","author":"Pinheiro","year":"2021","journal-title":"BMC Womens Health"},{"key":"2026031312490194800_ref30","first-page":"149","article-title":"Transcutaneous Temperature Controlled Radiofrequency (TTCRF) for the treatment of menopausal vaginal\/genitourinary symptoms","volume":"29","author":"Leibaschoff","year":"2016","journal-title":"Surg Technol Int"},{"issue":"4","key":"2026031312490194800_ref31","doi-asserted-by":"publisher","first-page":"342","DOI":"10.23736\/S0026-4784.17.04072-2","article-title":"Dynamic quadripolar radiofrequency treatment of vaginal laxity\/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety","volume":"69","author":"Vicariotto","year":"2017","journal-title":"Minerva Ginecol"},{"issue":"2","key":"2026031312490194800_ref32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jsxm.2016.11.322","article-title":"Effect of single-treatment, surface-cooled radiofrequency therapy on vaginal laxity and female sexual function: the VIVEVE I randomized controlled trial","volume":"14","author":"Krychman","year":"2017","journal-title":"J Sex Med"},{"issue":"11","key":"2026031312490194800_ref33","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s00192-016-3020-x","article-title":"Radiofrequency in female external genital cosmetics and sexual function: a randomized clinical trial","volume":"27","author":"Lord\u00ealo","year":"2016","journal-title":"Int Urogynecol J"},{"issue":"5","key":"2026031312490194800_ref34","doi-asserted-by":"publisher","first-page":"213","DOI":"10.7224\/1537-2073.2020-039","article-title":"Effectiveness of physical therapy in addressing sexual dysfunction in individuals with multiple sclerosis: a systematic review and meta-analysis","volume":"23","author":"Gopal","year":"2021","journal-title":"Int J MS Care"},{"issue":"5","key":"2026031312490194800_ref35","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.jsxm.2019.03.001","article-title":"The Female Sexual Function Index (FSFI): a systematic review of measurement properties","volume":"16","author":"Neijenhuijs","year":"2019","journal-title":"J Sex Med"},{"key":"2026031312490194800_ref36","doi-asserted-by":"publisher","first-page":"e1750","DOI":"10.6061\/clinics\/2020\/e1750","article-title":"Impact of microablative fractional radiofrequency on the vaginal health, microbiota, and cellularity of postmenopausal women","volume":"75","author":"Sarmento","year":"2020","journal-title":"Clinics (S\u00e3o Paulo)"},{"key":"2026031312490194800_ref37","volume-title":"Genitourinary Syndrome of Menopause: FEBRASGO Position Statement Number 3","author":"Brazilian Federation of Gynecology and Obstetrics Associations (FEBRASGO)","year":"2022"}],"container-title":["Sexual Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/smr\/article-pdf\/14\/1\/qeag013\/67340882\/qeag013.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/smr\/article-pdf\/14\/1\/qeag013\/67340882\/qeag013.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:49:10Z","timestamp":1773420550000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/smr\/article\/doi\/10.1093\/sxmrev\/qeag013\/8519454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,5]]}},"URL":"https:\/\/doi.org\/10.1093\/sxmrev\/qeag013","relation":{},"ISSN":["2050-0513","2050-0521"],"issn-type":[{"value":"2050-0513","type":"print"},{"value":"2050-0521","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2026,1]]},"article-number":"qeag013"}}